Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Coumestrol from the national cancer Institute’s natural product library is a novel inhibitor of protein kinase CK2

  • Shu Liu1,
  • David Hsieh1,
  • Yi-Lin Yang1,
  • Zhidong Xu1,
  • Csaba Peto1,
  • David M Jablons1 and
  • Liang You1Email author
Contributed equally
BMC Pharmacology and Toxicology201314:36

DOI: 10.1186/2050-6511-14-36

Received: 18 March 2013

Accepted: 5 July 2013

Published: 11 July 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
18 Mar 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
17 Apr 2013 Reviewed Reviewer Report - Cheryl Watson
2 May 2013 Reviewed Reviewer Report - Laura Moro
4 Jun 2013 Author responded Author comments - Shu Liu
Resubmission - Version 3
4 Jun 2013 Submitted Manuscript version 3
7 Jun 2013 Reviewed Reviewer Report - Cheryl Watson
17 Jun 2013 Reviewed Reviewer Report - Laura Moro
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
5 Jul 2013 Editorially accepted
11 Jul 2013 Article published 10.1186/2050-6511-14-36

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Thoracic Oncology Laboratory, Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California

Advertisement